A biotech company is hoping to cash in on a genetically modified salmon. If the F-D-A approves the fish, it would be the first transgenic animal species available for human consumption. The Great Lake Radio Consortium’s Nancy Cohen reports:
Transcript
A biotech company is hoping to cash in on a genetically modified
salmon. If the FDA approves the fish, it would be the first transgenic
animal species available for human consumption. The Great Lake Radio
Consortium’s Nancy Cohen reports:
Aquaculture firms are developing fish that are resistant to disease,
consume low-cost diets and grow faster. The Massachusetts-based Aqua
Bounty Technologies took part of the genetic code from a fish called the
ocean pout, and added it to the Atlantic salmon. The ocean pout’s
genetic material acts as a kind of switch that turns on the salmon’s
growth regulators.
Joe McGonigle is with Aqua Bounty. He says the result is a salmon that
grows twice as fast as other farmed salmon.
“You can get more heart healthy omega 3 protein on the market at a
lower price, you can produce fish more quickly, you can use fewer
resources and you can manage water quality and fish health, in a much
better way than under current conditions.”
But critics are concerned about the environmental impact on native fish
populations if genetically modified fish were to escape into the wild.
For the GLRC, I’m Nancy Cohen.
